"BilipidexTM is a Trade Mark of TAASI Corporation/The Attia Applied Sciences Inc."
ABOUT TAASI
TAASI Corporation
TAASI Corporation, also known as The Attia Applied Sciences Incorporated, was founded in the State of Ohio, U.S.A., in 1985 by Dr. Yosry A. Attia, to commercialize promising new technologies. Dr. Attia, recognized the potential of Aerogel and since 1991, he has worked exclusively on Aerogel technologies in his personally funded laboratory and pilot plant facility. Dr. Attia is a recognized International Scientist in his field, and had previously worked for The Ohio State University and Battelle Columbus Laboratories.
Through extensive research and experimentation, TAASI has developed a pilot plant manufacturing system for multi-metal oxide Aerogels.
This process produces Aerogel in a wide variety of physical and chemical forms, making Aerogel technology available for a number of market applications and customizable product opportunities.
The objective of TAASI is to become a major manufacturer of commercial Aerogel materials and technologies for wide-scale applications in industrial, commercial, and consumer products markets at a cost-effective price. Because of TAASI’s unique combination of expertise in both Aerogel technologies and industrial processing sciences and technologies, it has the ability to work side-by side with its clients across many application fields. This enables TAASI to design Aerogel products and technologies that best meet the client’s needs and requirements
TAASI has teamed up with several companies for the commercial development of Aerogel technologies, and continues to actively seek strategic partners and joint ventures to expedite the wide-scale commercialization of these promising Aerogel materials.
Excess Fat Linked To Cancer
A recently published article: “Strong Evidence; Obesity Tied to Eleven Cancers”, by Nick Mulcahy, www.medscape.com, February 28, 2017; Reported that:
Based on many reliable international studies, strong evidence was found between excess body fat and eleven types of Cancer: esophageal adenocarcinoma (cancer of the esophagus), multiple myeloma (bone marrow cancer), colon, rectum, bile tract system, pancreas, breast (postmenopausal), endometrium (premenopausal), ovary, kidney and cancers of the gastric cardia. Excess fat is also linked to liver, thyroid and intestinal cancers.
REDUCING EXCESS BODY FAT LOWERS THE RISKS OF DEVELOPING AND DYING OF THESE CANCERS.
OBESITY - Worldwide Threat:
According to an analysis of global trends in body mass index, more than 640 million people globally now weigh in as obese and the world has more overweight than underweight people. This epidemic of severe obesity is way too extensive to be tackled with medications such as blood pressure lowering drugs or diabetes treatments alone. Globally 387 million people have diabetes, that is 8.3 of the world’s population and nearly half do not realize why they have it. Excess fat could lead to heart disease, stroke, blindness, kidney failure, type-2 diabetes [high blood sugar], amputation of the legs and feet. [Source Reference: Kate Kelland, Reuters, March31-April 1, 2016].
TYPE-2 Diabetes Death Toll Is Bigger Than Expected
People with diabetes have another reason to take care of their health, it is deadlier than previously believed and underreported as a factor compared too many illnesses. Type 2 diabetes in which the body doesn’t make enough insulin or cannot use it properly used to be an adult problem, but is now showing up in kids and teens as well. Researchers say obesity is on the rise in children, because they are less active. [Source reference: Nanci Hellmich; U.S. News & World Report, Health]. The Ancient Egyptians described diabetes and remedies 3,000 years ago.
THE SOLUTION OF ALL OF THESE COSTLY HEALTH ISSUES IS TO REDUCE BODY FAT AND FAT INTAKE.
BILIPIDEX IS THE MOST PROMISING AND AFFORDABLE SOLUTION TO EXCESS FAT CAUSED DISEASES. “TAKE CARE OF YOUR HEALTH AND YOUR WEALTH”!
© 2017, TAASI Aerogel Technologies All Rights Reserved.
Site By :